• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因表达谱分析确定CAV1、CD44和TFRC为多发性骨髓瘤的潜在诊断标志物和治疗靶点。

Gene Expression Profiling Identifies CAV1, CD44, and TFRC as Potential Diagnostic Markers and Therapeutic Targets for Multiple Myeloma.

作者信息

Ali Awais, Ali Syed Luqman, Ullah Waseef, Khan Asifullah

机构信息

Department of Biochemistry, Abdul Wali Khan University Mardan (AWKUM), Mardan, Pakistan.

出版信息

Cell Biochem Biophys. 2025 Apr 17. doi: 10.1007/s12013-025-01743-0.

DOI:10.1007/s12013-025-01743-0
PMID:40246772
Abstract

Multiple myeloma (MM) is a highly malignant hematological tumor with a low overall survival rate, making the identification of innovative prognostic markers essential due to its complex and heterogeneous nature. Ferroptosis, an iron-dependent form of cell death driven by lipid peroxidation, is now recognized as crucial in tumor development and progression. Consequently, ferroptosis-related genes (FRGs) are emerging as promising therapeutic targets and prognostic indicators. However, the specific roles and predictive value of FRGs in MM still remain unclear. The current study was therefore conceived to examine the possible involvement of FRGs in MM. FRGs data was obtained from the FerrDb resource. The datasets GSE133346 and GSE166122, sourced from the Gene Expression Omnibus (GEO), provided gene expression data for both healthy and MM individuals. The differentially expressed-FRGs (DE-FRGs) were identified using the limma and DESeq2 packages in R. Functional pathways were analyzed through Gene Ontology (GO) and KEGG enrichment analyses. The miRWalk database was used for miRNA association and enrichment analysis with hub genes. Prognosis-related genes were evaluated using Kaplan-Meier survival analyses. We identified 1400 differentially expressed genes and cross-referenced them with FRGs, ultimately selecting 17 as DE-FRGs or hub genes. GO analysis revealed that the primary enriched functions of these hub genes are sister chromatid segregation, condensed chromosome centromeric region, C-C chemokine receptor activity, and C-C chemokine binding. KEGG pathway analysis showed that these overlapped genes were enriched in several pathways, including cell cycle, viral protein interaction with cytokine and cytokine receptor, as well as breast and prostate cancers involved pathways. Furthermore, significant enrichment was observed in glycolysis, gluconeogenesis, and the citrate cycle pathways based on miRNAs association with the candidate genes. The CAV1, CD44, TFRC, DPP4, and GJA1 are identified as top five significant hub DE-FRGs based on protein-protein interaction (PPI) analysis from multiple resources. Survival analysis eventually identified CAV1, CD44, and TFRC as the top-ranked DE-FRGs associated with overall survival, underscoring their crucial role in MM. This study identifies CAV1, CD44, and TFRC as key FRGs associated with the prognosis of MM, suggesting their potential as valuable prognostic markers and therapeutic targets to improve patient outcomes.

摘要

多发性骨髓瘤(MM)是一种高度恶性的血液肿瘤,总体生存率较低,由于其性质复杂且具有异质性,因此识别创新的预后标志物至关重要。铁死亡是一种由脂质过氧化驱动的铁依赖性细胞死亡形式,现在被认为在肿瘤的发生和发展中起着关键作用。因此,铁死亡相关基因(FRGs)正成为有前景的治疗靶点和预后指标。然而,FRGs在MM中的具体作用和预测价值仍不清楚。因此,本研究旨在探讨FRGs在MM中可能的作用。FRGs数据来自FerrDb资源。来自基因表达综合数据库(GEO)的数据集GSE133346和GSE166122提供了健康人和MM患者的基因表达数据。使用R语言中的limma和DESeq2软件包鉴定差异表达的FRGs(DE-FRGs)。通过基因本体论(GO)和KEGG富集分析对功能途径进行分析。miRWalk数据库用于miRNA与枢纽基因的关联和富集分析。使用Kaplan-Meier生存分析评估预后相关基因。我们鉴定出1400个差异表达基因,并将它们与FRGs进行交叉比对,最终选择了17个作为DE-FRGs或枢纽基因。GO分析显示,这些枢纽基因的主要富集功能是姐妹染色单体分离、浓缩染色体着丝粒区域、C-C趋化因子受体活性和C-C趋化因子结合。KEGG通路分析表明,这些重叠基因在多个通路中富集,包括细胞周期、病毒蛋白与细胞因子及细胞因子受体的相互作用,以及涉及乳腺癌和前列腺癌的通路。此外,基于miRNA与候选基因的关联,在糖酵解、糖异生和柠檬酸循环通路中观察到显著富集。基于多种资源的蛋白质-蛋白质相互作用(PPI)分析,CAV1、CD44、TFRC、DPP4和GJA1被确定为前五个重要的枢纽DE-FRGs。生存分析最终确定CAV1、CD44和TFRC是与总生存相关的排名靠前的DE-FRGs,突出了它们在MM中的关键作用。本研究确定CAV1、CD44和TFRC是与MM预后相关的关键FRGs,表明它们作为有价值的预后标志物和治疗靶点以改善患者预后的潜力。

相似文献

1
Gene Expression Profiling Identifies CAV1, CD44, and TFRC as Potential Diagnostic Markers and Therapeutic Targets for Multiple Myeloma.基因表达谱分析确定CAV1、CD44和TFRC为多发性骨髓瘤的潜在诊断标志物和治疗靶点。
Cell Biochem Biophys. 2025 Apr 17. doi: 10.1007/s12013-025-01743-0.
2
A prognostic model for multiple myeloma based on lipid metabolism related genes.基于脂质代谢相关基因的多发性骨髓瘤预后模型
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 Apr 28;50(4):517-530. doi: 10.11817/j.issn.1672-7347.2025.240592.
3
Identification of osteoporosis ferroptosis-related markers and potential therapeutic compounds based on bioinformatics methods and molecular docking technology.基于生物信息学方法和分子对接技术鉴定骨质疏松症铁死亡相关标志物和潜在治疗化合物。
BMC Med Genomics. 2024 Apr 22;17(1):99. doi: 10.1186/s12920-024-01872-0.
4
Integrated bioinformatics identifies ferroptosis biomarkers and therapeutic targets in idiopathic pulmonary arterial hypertension.整合生物信息学鉴定特发性肺动脉高压中的铁死亡生物标志物和治疗靶点。
Sci Rep. 2025 Jul 12;15(1):25187. doi: 10.1038/s41598-025-11066-y.
5
Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation.小窝蛋白-1通过表皮生长因子受体(EGFR)降解抑制肺腺癌的增殖和侵袭。
Sci Rep. 2025 Jul 1;15(1):21654. doi: 10.1038/s41598-025-05259-8.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Decoding ferroptosis in ischemic stroke: key genes and the therapeutic potential of acupuncture.解读缺血性中风中的铁死亡:关键基因与针灸的治疗潜力
Front Aging Neurosci. 2025 Jun 9;17:1506276. doi: 10.3389/fnagi.2025.1506276. eCollection 2025.
8
Ferroptosis-related hub genes and immune cell dynamics as diagnostic biomarkers in age-related macular degeneration.铁死亡相关枢纽基因和免疫细胞动态变化作为年龄相关性黄斑变性的诊断生物标志物
Eur J Med Res. 2025 Aug 20;30(1):777. doi: 10.1186/s40001-025-03044-x.
9
From gene expression to causal associations: investigating the role of ferroptosis in cataract development.从基因表达到因果关联:探究铁死亡在白内障发生发展中的作用
BMC Med Genomics. 2025 Jul 1;18(1):111. doi: 10.1186/s12920-025-02177-6.
10
Ferroptosis-related genes, a novel therapeutic target for focal segmental glomerulosclerosis.铁死亡相关基因:局灶节段性肾小球硬化症的新治疗靶点。
BMC Nephrol. 2024 Feb 17;25(1):58. doi: 10.1186/s12882-024-03490-5.

本文引用的文献

1
The clinical significance of endoplasmic reticulum stress related genes in non-small cell lung cancer and analysis of single nucleotide polymorphism for CAV1.内质网应激相关基因在非小细胞肺癌中的临床意义及CAV1单核苷酸多态性分析
Front Mol Biosci. 2024 Aug 6;11:1414164. doi: 10.3389/fmolb.2024.1414164. eCollection 2024.
2
Class II ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma.Ⅱ类铁死亡诱导剂是治疗 t(4;14)阳性多发性骨髓瘤的一种新方法。
Blood Adv. 2024 Oct 8;8(19):5022-5038. doi: 10.1182/bloodadvances.2023010335.
3
Expression of transferrin receptor/TFRC protein in bladder cancer cell T24 and its role in inducing iron death in bladder cancer.
转铁蛋白受体/TFRC 蛋白在膀胱癌 T24 细胞中的表达及其诱导膀胱癌铁死亡的作用。
Int J Biol Macromol. 2024 Aug;274(Pt 1):133323. doi: 10.1016/j.ijbiomac.2024.133323. Epub 2024 Jun 20.
4
Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors.整合公共数据集以发现和验证实体瘤中与生存相关的基因
Innovation (Camb). 2024 Apr 9;5(3):100625. doi: 10.1016/j.xinn.2024.100625. eCollection 2024 May 6.
5
The prognostic value of co-expression of stemness markers CD44 and CD133 in endometrial cancer.干性标志物CD44和CD133共表达在子宫内膜癌中的预后价值。
Front Oncol. 2024 Apr 19;14:1338908. doi: 10.3389/fonc.2024.1338908. eCollection 2024.
6
CD44: A New Prognostic Marker in Colorectal Cancer?CD44:结直肠癌的一种新的预后标志物?
Cancers (Basel). 2024 Apr 19;16(8):1569. doi: 10.3390/cancers16081569.
7
NCBI GEO: archive for gene expression and epigenomics data sets: 23-year update.NCBI GEO:基因表达和表观基因组数据集的归档:23 年的更新。
Nucleic Acids Res. 2024 Jan 5;52(D1):D138-D144. doi: 10.1093/nar/gkad965.
8
N7-methylguanosine-related miRNAs predict hepatocellular carcinoma prognosis and immune therapy.N7-甲基鸟苷相关 miRNA 预测肝细胞癌预后和免疫治疗。
Aging (Albany NY). 2023 Nov 3;15(21):12192-12208. doi: 10.18632/aging.205172.
9
Correlation Between Early Trends of a Prognostic Biomarker and Overall Survival in Non-Small-Cell Lung Cancer Clinical Trials.非小细胞肺癌临床试验中预后生物标志物的早期趋势与总生存期的相关性。
JCO Clin Cancer Inform. 2023 Sep;7:e2300062. doi: 10.1200/CCI.23.00062.
10
Detection of lineage-reprogramming efficiency of tumor cells in a 3D-printed liver-on-a-chip model.在 3D 打印的肝芯片模型中检测肿瘤细胞的谱系重编程效率。
Theranostics. 2023 Sep 4;13(14):4905-4918. doi: 10.7150/thno.86921. eCollection 2023.